The US FDA GMP inspection performed on Shilpa Medicare Limited s Analytical Services Division situated on first Floor of Unit 7, Nacharam, Hyderabad, Telangana, has been cleared with a status of voluntary action indicated.
BENGALURU (Reuters) - Indian shares are set to open higher on Tuesday ahead of corporate earnings for the March quarter, and amid caution on rising odds of a U.S. Federal Reserve rate hike in May. | 10:42pm
Shilpa Medicare share price: The stock was last seen trading higher than the 5-day, 20- and 50-day moving averages but lower than the 100-day and 200-day moving averages. The counter's 14-day relative strength index (RSI) came at 57.82. The company's stock has a price-to-equity (P/E) ratio of 16.65.
Shilpa Medicare Ltd has received U.S Food and Drug Administration final approval for its ANDA, Apremilast Tablets, 10 mg, 20 mg, and 30 mg for the treatment of adult patients with active psoriatic arthritis. The product is executed from a contract manufac